+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celyad - logo

Celyad SA, a clinical-stage biopharmaceutical company, focuses on engineered cell therapy treatments. It develops therapeutic therapies for the treatment of unmet medical needs in cardiology and oncology. The company's best known product is the C-Cure, an autologous cell therapy for the treatment of heart failure. The company was formerly known as Cardio3 BioSciences SA and changed its name to Celyad SA in May 2015. Celyad SA was founded in 2004 and is based in Mont-Saint-Guibert, Belgium.

Myelodysplastic Syndrome - Pipeline Review, H1 2020 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1667 Pages
  • Global
From
From
From
From
NK Cell therapies - Pipeline Insight, 2024 - Product Thumbnail Image

NK Cell therapies - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Tumor Infiltrating Lymphocytes Global Market Report 2024 - Product Thumbnail Image

Tumor Infiltrating Lymphocytes Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
CAR-T Therapy Global Market Report 2024 - Product Thumbnail Image

CAR-T Therapy Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Immuno-Oncology Drugs Global Market Report 2024 - Product Thumbnail Image

Immuno-Oncology Drugs Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
CAR-T - Pipeline Insight, 2024 - Product Thumbnail Image

CAR-T - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 450 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1150 Pages
  • Global
From
Royalty Rates in Pharmaceutical and Biotechnology Deals - Product Thumbnail Image

Royalty Rates in Pharmaceutical and Biotechnology Deals

  • Report
  • August 2024
  • 500 Pages
  • Global
From
Colorectal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Colorectal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 550 Pages
  • Global
From
Acute Myeloid Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Myeloid Leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
Multiple Myeloma - Pipeline Insight, 2024 - Product Thumbnail Image

Multiple Myeloma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
From
Loading Indicator